Palatin has a research program in DR, and more specifically, in diabetic macular edema (DME), a complication of DR that ...

The agreement with Palatin follows a $1bn deal with Re-Vana earlier this year as Boehringer targets the ophthalmology market.

For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy, according to a review published online Aug. 14 in JAMA Ophthalmology.

Fully autonomous screening for diabetic retinopathy is coming to pharmacies and other locations through a strategic ...

Your eyes can reveal hidden health risks like cancer, diabetes, and high blood pressure before other symptoms appear. Learn ...

Comprehensive eye exams are vital for detecting early signs of systemic diseases like diabetes, hypertension, and high ...

Eye floaters, those drifting spots in your vision, are often harmless but can signal hypertension or diabetes. High blood ...

Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

The Sultanate of Oman is the third country worldwide to implement this project, confirming its commitment to technological ...

This phase 2b/3 trial follows new, positive 2-year data from the phase 2 ALTITUDE trial, in which sura-vec was well-tolerated ...